Skip to content
‹ Back to IndustriesHealthcare

TECHNOLOGY READINESS ASSESSMENTS AND MITIGATIONS

New product development efforts are a significant investment. Whether it is an established company that is acquiring new technology, or a startup with a new product concept hoping to move to commercialization; decisions should be made regarding what needs to be de-risked before moving to formal product development. Integrating technology readiness reviews into the product…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

New product development efforts are a significant investment. Whether it is an established company that is acquiring new technology, or a startup with a new product concept hoping to move to commercialization; decisions should be made regarding what needs to be de-risked before moving to formal product development.

Integrating technology readiness reviews into the product development process enables actionable processes that reduce project risk. This helps to avoid project delays, potential budgetary concerns, or the pressure to make design/feature compromises.

To determine whether a potential product has adequate technical maturity to effectively launch formal product development, the following steps should be considered:

  • Determine the stage of maturity of the current technology
  • Understand the implications of technology and project risks
  • Model, take measurements and analyze to decide whether core technology is capable of meeting the product requirements
  • Demonstrate that the device can provide adequate performance over the expected range of conditions
  • Determine whether the technology can scale to volume manufacturing and distribution

Evaluations begin with an objective review of each core technology critical to the operability of the device that may delay or prohibit market introduction.

This may involve proving whether core technology is adequate for use in a particular application. For example, does the new sensor being developed operate over the variety of conditions needed? Will environmental effects cause problems? Are measurements and control mechanisms adequate to provide safe and effective outcomes? Are there manufacturing difficulties in achieving the needed tolerances? These and other questions are explored, and appropriate efforts made, to bring the technology readiness level to the point that justifies moving the project to its subsequent phases.

Technology Readiness Assessment Tailored to Medical Devices

At Sunrise Labs, we implement a rigorous Technology Readiness Assessment customized specifically for medical devices. By analyzing the maturity of the technologies and the risk that each stage incurs, our assessment determines what challenges must be overcome in order for a device to be successfully engineered and commercialized.

We then improve the Technology Readiness through our feasibility Phase 0 process to prepare for a successful development effort.

To learn more about our process, check out our video on Technology Readiness.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

AI Takes Center Stage at AHA 2026. Experts Warn It Must Be Built for Everyone

AI Takes Center Stage at AHA 2026. Experts Warn It Must Be Built for Everyone

AI-enabled ECG, echocardiography and imaging studies are a major theme at the American Heart Association's Scientific Sessions 2026 in Chicago, November 6 to 9. A Frontiers in Cardiovascular Medicine policy brief led by Emory cardiologist Dr. Jose R. Medina-Inojosa argues precision cardiology must be designed with equity from inception. He says the biggest factor is not algorithm accuracy but the pathway from result to clinical action.

  • 01AHA 2026 late-breakers on AI include WATCH-LV, AI ECHO INSIGHT, PROVAR+ and LIFE-AI, all presented Monday, November 9.
  • 02Medina-Inojosa says equity from inception means training and validating on representative data and reporting subgroup performance before deployment.
  • 03Programs in Nigeria and Uganda show AI-ECG and AI-guided echo can extend cardiac care where specialists are scarce.

Nov 1, 2026

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Ambulatory surgery center volumes are projected to rise 24% over the next decade, with anesthesiology and gastroenterology shortages projected for 2027. That puts potential staffing constraints early in the growth period, so operators planning coverage may find the nearer 2027 date sets the pace.

  • 01A 24% ten-year forecast and a 9% forecast for 2023 to 2028 measure different windows; check the time frame and start year before putting either in a budget.
  • 02With about nine in ten ASCs at least partly physician-owned, a staffing gap could hit physician owners directly as clinicians and investors.

Oct 30, 2026

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea CEO Nikos Paragios said at ASTRO 2026 in Boston that vendor-agnostic AI software like ART-Plan can raise radiotherapy throughput on existing machines. A February 2025 Lancet Oncology study puts the global linac shortfall at 30%, with 36 of 181 countries owning no linac, limiting how far software alone can go.

  • 01A February 2025 Lancet Oncology study found a global median Linac Shortage Index of 130, a 30% capacity shortfall, and 36 of 181 countries with no linac at all.
  • 02Bundled adaptive systems already exist: Varian’s Ethos won FDA clearance in February 2020 and RaySearch demoed automated replanning at ASTRO, but buyers still need to validate acceptability and sign-off workflows.

Oct 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512